Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > In the Hot Seat > Stella Kyriakides: EU Commissioner for Health
  • In the Hot Seat

Stella Kyriakides: EU Commissioner for Health

  • 2 November 2020
  • Alberto Costa
Stella Kyriakides: EU Commissioner for Health
Total
0
Shares
0
0
0
0
0

When Stella Kyriakides took on the post of EU Health Commissioner in September 2019, Europe’s cancer community knew they could trust her to fight their cause. Within months she was launching a public consultation on Europe’s Beating Cancer Plan. Then came COVID. Alberto Costa asked her how her experience as a breast cancer survivor and patient advocate shaped her approach to her new role and how she is coping with the demands of responding to a major public health crisis while still delivering on the expectations of the cancer community.

Cancer World: You were still becoming familiar with your new office at the Berlaymont in Brussels when the COVID-19 pandemic exploded. How did you respond?

Stella Kyriakides: In Greek, there is a saying: “In difficult situations, you just roll up your sleeves and get the work done.” There was no option but to do everything to rise to the challenge of the greatest public health crisis in memory. Quickly getting a grasp of the issues at hand, ensuring we have the right expertise in place, connecting the dots to our Member States and European Parliament, and finding pragmatic, concrete and workable solutions as quickly as possible in a calm and effective way. The COVID-19 crisis has affected the lives of countless citizens and businesses around the globe. As European Commissioner for Health and Food Safety, it is my responsibility to ensure that we do everything we can to protect public health. It is important to be prepared for any eventuality at all times, and be ready to react swiftly. We have faced countless challenges since the beginning of the pandemic. However, these challenges and difficulties cannot in any way be compared to those faced on a daily basis by frontline workers. Despite unprecedented pressure, and in the most difficult of circumstances, they continue to provide lifesaving treatment and care to thousands of citizens, and to put themselves at risk every day to protect us all. They are the true heroes of the COVID era. Clapping for the carers night after night was one of the many inspiring acts of solidarity we witnessed across Europe during this crisis.

CW: You’ve been a Member of Parliament for many years in your home country, Cyprus, where problems have relatively limited dimensions. How does it feel to now have such a huge responsibility at a European level?

SK: It is of course a great responsibility, but I have always approached every personal challenge in a similar way: setting high targets, working hard and giving my best to deliver on expectations. This means, among other things, to be able to work in effective teams, in a coordinated and focused way, taking all viewpoints on board, having flexibility when needed to find solutions – much more so when we find ourselves in unprecedented crisis situations.
This tragedy we are experiencing in Europe and the world has had an immeasurable cost, primarily on human lives, but also on our economies, on society at large and, unfortunately, much more on those most vulnerable amongst us.

CW: Europe’s cancer community is expecting great things from your Beating Cancer Plan. What are you trying to achieve with it and how?

SK: Every year, 3.5 million people in the EU are diagnosed with cancer, and 1.3 million die from it. Many of us have personal experiences and know the pain it causes for those we love. This is why the high expectations that you mention are justified and why Europe’s Beating Cancer Plan is a major priority for myself and for the whole von der Leyen Commission. Our aim is to reduce the cancer burden for patients, their families and health systems, focusing on: prevention through healthier lifestyles; improved screening and early detection; and equal access to medicines and innovative treatments. With this focus, we are aiming to achieve a better quality of life for cancer patients, for those living with advanced disease, for survivors and carers. In recent months, we have also seen how the COVID-19 pandemic has affected cancer prevention and care, underlining the importance of robust and resilient health systems that function in all circumstances. Europe has been actively working to fight cancer for decades. We are committed to presenting the Europe Beating Cancer Plan by the end of this year. This could not be more personal for me – as it is also for so many of us.

CW: As a pioneer of cancer patient advocacy, you gave time and energy to Europa Donna and to the breast cancer world. What does this bring to your role as Health Commissioner?

SK: Being a breast cancer patient and patient advocate has been part of my journey in the area of health for over twenty years. This could not but influence my life in the public sphere from my time as a parliamentarian in Cyprus and now as European Commissioner. I firmly believe patients need to have a central seat at the table when decisions about them are made, because their voices need to be heard. Equally, I have learned that we all need to work together with all stakeholders to bring about change. This means bringing together patients, scientists, decision makers, industry, etc. This is the only way we can bring change. That has always been my belief as an advocate and it continues to be my compass now in my role as Commissioner.

CW: Most politicians are men. Do you as a woman struggle more than your male colleagues to combine your political position with your personal and family life?

SK: Equality is a founding principle of the EU and an integral part of our Charter of Fundamental Rights. I am very proud to be part of the first European Commission led by a woman, in the most gender-balanced Commission College we have ever had. On a personal note, I was lucky with the fact that I had supportive parents, and a supportive husband and children, so my gender was not limiting. But many women in the world are not so fortunate, and I have been witness to this discrimination – it is for these women that we must act. Gender equality requires political will and political vision. And it requires us all to be the strongest advocates for gender equality. This is a cause I have championed in the past, and which I will continue to champion for as long as I am in public life

Stella Kyriakides is Cypriot politician who was appointed European Commissioner for Health and Food Safety in 2019. She has represented the Nicosia district in the Cypriot national parliament since 2006, and represented Cyprus at the Parliamentary Assembly of the Council of Europe (PACE) between 2012 and 2019, serving as president of PACE in 2018–2019. Her professional training and early career was in the field of clinical psychology. After being diagnosed with breast cancer she got involved in cancer patient advocacy, serving as president of Europa Donna, the European Breast Cancer Coalition, between 2004 and 2006. She has consistently championed the cause of cancer patients and survivors throughout her political career.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • Europa Donna
  • European Union
  • patient advocacy
  • policy
Alberto Costa

Previous Article
  • Interviews to the Expert

Dose dense chemotherapy in Luminal B breast cancers

  • 26 October 2020
  • Alberto Costa
View Post
Next Article
  • Interviews to the Expert

Cervical cancer: the SENTIX trial

  • 3 November 2020
  • Alberto Costa
View Post
You May Also Like
View Post
  • In the Hot Seat

Manfred Weber – chair of the European Parliament EPP group

  • Alberto Costa
  • 30 April 2021
View Post
  • In the Hot Seat

Solange Peters: ESMO President

  • Editorial Staff
  • 6 July 2020
search
CancerWorld #101 Download CancerWorld #101 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study
    • 8 May 2025
  • What Caught Our Eye in April: Oncology’s Top Moments
    • 7 May 2025
  • CancerWorld #102 (April 2025)
    • 22 April 2025
  • What Caught Our Eye in March: Oncology’s Top Moments
    • 8 April 2025
  • Ovarian cancer: mechanism conferring resistance to immunotherapy revealed
    • 21 March 2025
Article
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
  • Istanbul, Ankara take action on HPV vaccination, as government delays promised national programme
    • 1 April 2025
  • Could this dual approach be the frontier that finally gets immunotherapy to work for MSS colorectal cancer?
    • 31 March 2025
Social

Would you follow us ?

Contents
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
  • “I really care about people.” – Philip Kantoff, A Life in Science and Medicine
    • 5 May 2025
  • What If the World’s Leading Prostate Cancer Epidemiologist Opened a Restaurant? A Conversation with Lorelei Mucci- A Harvard Scientist, A Mother, A Leader
    • 23 April 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.